TScan Founders Lea Hachigian and Tomasz Kula Named in Forbes 2020 “30 Under 30” List December 10, 2019
TScan Therapeutics Announces Pioneering Publication in Scientific Journal Cell Describing New Methods to Identify Targets for T Cell Receptor Immunotherapy August 12, 2019
TScan Therapeutics Formed to Overcome Challenges of Current Immunotherapies with Novel TCR Discovery Platform and $48 Million in Funding July 24, 2019
